Postexposure prophylaxis (PEP) is a type of medication that can help prevent HIV from developing in people who may have experienced exposure to the virus. A person can get PEP after speaking with ...

According to the CDC, if you’re prescribed post-exposure prophylaxis (PeP) medications and you cannot get insurance coverage (Medicaid, Medicare, private or employer-based), your health care provider ...

In the UK the recommended first-line PEP medications of emtricitabine/tenofovir and raltegravir are generally well tolerated by most people. Nonetheless, some people do have short-term problems with ...

We recently published a list of Jim Cramer’s Latest Lightning Round: Top 10 Stocks. In this article, we are going to take a ...

The rates of chlamydia and syphilis declined dramatically among individuals living with HIV who were prescribed doxycycline ...

Three laws regarding the healthcare industry will see an impact on both staff and patients in Washington and Idaho on January ...

At the beginning of 2025, a suite of fifteen Washington bills became law, transforming key areas from health care to workers' ...

As health care services begin offering doxycycline to prevent bacterial sexually transmitted infections (STIs), real-world evidence demonstrates that the postexposure strategy, called doxy PEP, is ...

PEP-CMV is under clinical development by Immunomic Therapeutics and currently in Phase I for Anaplastic Astrocytoma.

Three laws regarding the healthcare industry will see an impact on both staff and patients in Washington and Idaho on January 1, 2025.

In the UK the recommended first-line PEP medications of emtricitabine/tenofovir and raltegravir are generally well tolerated by most people. Nonetheless, some people do have short-term problems with ...